zyrwex

GITLAB is overvalued

Penjualan
zyrwex Diupdate   
NASDAQ:GTLB   GitLab Inc.
Fundamentals:

- has massive competitors such as Microsoft (MSFT), Amazon (AMZN), Oracle (ORCL), International Business Machines (IBM), and Atlassian Corp (TEAM)such as Microsoft (MSFT), Amazon (AMZN), Oracle (ORCL), International Business Machines (IBM), and Atlassian Corp (TEAM)

- competitors are all profitable; Gitlab is not.

- Gitlab's NOPAT Margin is -141% and ROIC is -76%.

- As of June 2021, GitLab had 30 million free users with just 15,356 paying users. GitLab has converted less than 1% of its user base.

- 13.65 Billion Marketcap is definitely ways too high

- 2 Analysts lowered their pricetargets for Gitlab after they released their earnings on 6th December. JP Morgan gave GTLB an neutral rating at 99$

Technical Analysis:

- looks like its bear-flagging: rising on very low volume. The long wicked candles reinforced the assumption.

- got rejected 2 times at 97$ resistance area in the last 2 days. Buyers losing momentum.



Komentar:
quick update.
7.1.2022

Increased my short at 77$.

Lockup period is expiring on the 10.1.2022.
This will increase the float if insiders are selling. Assuming that IPO investors paid way less than IPO price, I think they want to get out with atleast a profit.

And always have a plan and set stop-losses.
Trading ditutup: target tercapai:
took profits. Waiting for the next setup to short
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.